Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (HKG:2315)
Hong Kong · Delayed Price · Currency is HKD 70.00
+5.30 (8.19%)
Sep 30, 2026, 4:08 PM HKT
HKG:2315 Market Cap
HKG:2315 has a market cap or net worth of 57.58 billion as of September 29, 2026. Its market cap has increased by 404.05% in one year.
Market Cap
57.58B
Enterprise Value
57.17B
Revenue
1.96B
Ranking
n/a
PE Ratio
70.58
Stock Price
70.00
ChartMarket Cap Chart
Since September 1, 2022, HKG:2315's market cap has increased from 10.31B to 57.58B, an increase of 458.24%. That is a compound annual growth rate of 52.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 29, 2026 | 55.00B | 133.19% |
| Dec 31, 2025 | 23.58B | 594.71% |
| Dec 31, 2024 | 3.39B | -29.05% |
| Dec 29, 2023 | 4.78B | -53.29% |
| Dec 30, 2022 | 10.24B | -0.67% |
| Sep 1, 2022 | 10.31B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sichuan Kelun-Biotech Biopharmaceutical | 111.62B |
| Sino Biopharmaceutical | 99.18B |
| Genscript Biotech | 97.92B |
| Akeso | 86.17B |
| RemeGen | 63.22B |
| 3SBio | 39.83B |
| Shanghai Junshi Biosciences | 35.97B |
| InSilico Medicine Cayman TopCo | 32.05B |